United States · FDA National Drug Code directory
Levothyroxine Sodium
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 66794-200_3f9e1bbc-d3e2-c795-e063-6394a90aecdf
- Product NDC
- 66794-200
- Form
- INJECTION
- Composition / generic term
- Levothyroxine Sodium
- Labeler
- Piramal Critical Care, Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20221001
- Source listing expiry
- 20261231
Source-listed ingredients
- LEVOTHYROXINE SODIUM ANHYDROUS — 100 ug/5mL
These values do not establish equivalence or a dose recommendation.
Packages
- 5 mL in 1 VIAL, SINGLE-USE (66794-200-02) · 66794-200-02
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →